ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AP55 | B | Sofosbuvir - 400mg, Velpatasvir - 100mg | 9935 | 20819/1 | EPCLUSA | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Gilead Sciences Ireland UC | Ireland | 15,191,424 L.L | 2.44 | E2 | Gilead Sciences Ireland UC | Ireland | 2/5/2024 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J05AP55 | B | Sofosbuvir - 400mg, Velpatasvir - 100mg | 9935/945 | 20819/1 | EPCLUSA | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Gilead Sciences Ireland UC | Ireland | 926,168,862 L.L | 2.44 | E2 | Gilead Sciences Ireland UC | Ireland | 2/5/2024 | 0 |